Compare ABT & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABT | ISRG |
|---|---|---|
| Founded | 1888 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8B | 202.9B |
| IPO Year | N/A | 2000 |
| Metric | ABT | ISRG |
|---|---|---|
| Price | $121.99 | $534.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 14 |
| Target Price | $147.56 | ★ $609.29 |
| AVG Volume (30 Days) | ★ 6.0M | 1.7M |
| Earning Date | 01-22-2026 | 01-22-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ 141.97 | 21.56 |
| EPS | ★ 7.96 | 7.56 |
| Revenue | ★ $43,843,000,000.00 | $9,612,000,000.00 |
| Revenue This Year | $7.57 | $21.14 |
| Revenue Next Year | $7.99 | $15.00 |
| P/E Ratio | ★ $15.29 | $70.78 |
| Revenue Growth | 6.37 | ★ 22.18 |
| 52 Week Low | $111.02 | $425.00 |
| 52 Week High | $141.23 | $616.00 |
| Indicator | ABT | ISRG |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 35.06 |
| Support Level | $122.20 | $528.00 |
| Resistance Level | $125.09 | $553.74 |
| Average True Range (ATR) | 2.11 | 13.11 |
| MACD | -0.28 | -5.59 |
| Stochastic Oscillator | 2.95 | 10.06 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.